AI Proteins is a series a startup. 2 investors tracked.
Based in the United States, AI Proteins is a startup. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
AI Proteins designs synthetic miniproteins from scratch using AI and high-throughput platforms, enabling precise control over protein function and pharmacology for therapeutic applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.